The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.
about
Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study.Impact of brand-name drug worship and expectation psychology on antidepressant efficacy
P2860
The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The backlash against bioequiva ...... brand-name and generic drugs.
@ast
The backlash against bioequiva ...... brand-name and generic drugs.
@en
type
label
The backlash against bioequiva ...... brand-name and generic drugs.
@ast
The backlash against bioequiva ...... brand-name and generic drugs.
@en
prefLabel
The backlash against bioequiva ...... brand-name and generic drugs.
@ast
The backlash against bioequiva ...... brand-name and generic drugs.
@en
P2860
P356
P1476
The backlash against bioequiva ...... f brand-name and generic drugs
@en
P2093
Aaron S Kesselheim
P2860
P304
P356
10.1503/CMAJ.110808
P407
P577
2011-07-11T00:00:00Z